[HTML][HTML] Blind Spots in Therapy: Unveiling Drug-Induced Angle-Closure Glaucoma Through a National Analysis

OM Aftab, H Khan, AS Khouri - Ophthalmology Glaucoma, 2024 - Elsevier
Objective To identify and quantify medications causing angle-closure glaucoma through the
FDA Adverse Event Reporting System (FAERS). Design National retrospective database …

[HTML][HTML] Blind Spots in Therapy: Unveiling Drug-Induced Angle-Closure Glaucoma Through a National Analysis

OM Aftab, H Khan, AS Khouri - Ophthalmology Glaucoma - ophthalmologyglaucoma.org
Structured Abstract Objective To identify and quantify medications causing angle-closure
glaucoma through the FDA Federal Adverse Event Reporting System (FAERS). Design …

Blind Spots in Therapy: Unveiling Drug-Induced Angle-Closure Glaucoma Through a National Analysis

OM Aftab, H Khan, AS Khouri - Ophthalmology. Glaucoma - pubmed.ncbi.nlm.nih.gov
Objective To identify and quantify medications causing angle-closure glaucoma through the
FDA Adverse Event Reporting System (FAERS). Design National retrospective database …

Blind Spots in Therapy: Unveiling Drug-Induced Angle-Closure Glaucoma Through a National Analysis.

OM Aftab, H Khan, AS Khouri - Ophthalmology. Glaucoma, 2024 - europepmc.org
Blind Spots in Therapy: Unveiling Drug-Induced Angle-Closure Glaucoma Through a National
Analysis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …

Blind Spots in Therapy: Unveiling Drug-Induced Angle-Closure Glaucoma Through a National Analysis

OM Aftab, H Khan, AS Khouri - Ophthalmology Glaucoma, 2024 - researchwithrutgers.com
Objective: To identify and quantify medications causing angle-closure glaucoma through the
FDA Adverse Event Reporting System (FAERS). Design: National retrospective database …